Skip to main content

Table 1 Patient baseline characters

From: Distant survival for patients undergoing surgery using volatile versus IV anesthesia for hepatocellular carcinoma with portal vein tumor thrombus: a retrospective study

Variables

TIVA (Nā€‰=ā€‰208)

INHA (Nā€‰=ā€‰263)

P value

Ā 

N (%)

N (%)

Ā 

Sex (male)

188 (90.4)

239 (90.9)

0.856

HBsAgā€‰āˆ’ā€‰+a

182 (87.5)

226 (85.9)

0.619

ASA

ā€ƒII

186 (89.4)

229 (87.1)

0.191

ā€ƒIII

22 (10.6)

30 (11.4)

Ā 

ā€ƒIV

0 (0)

4 (1.5)

Ā 

Child-Pugh

ā€ƒA

184 (88.5)

233 (88.6)

0.662

ā€ƒB

22 (10.6)

25 (9.5)

Ā 

ā€ƒC

2 (0.4)

5 (1.1)

Ā 

AFP (ug/L)

ā€ƒ<ā€‰25

30 (14.4)

54 (20.5)

0.109

ā€ƒ25ā€“399

39 (18.8)

45 (17.1)

Ā 

ā€ƒ400ā€“999

12 (5.8)

25 (9.5)

Ā 

ā€ƒā‰„ā€‰1000

127 (61.1)

139 (52.9)

Ā 

Tumor Diameter (cm)

ā€ƒ<ā€‰5

1 (0.4)

2 (0.8)

0.546

ā€ƒ5ā€“9.9

22 (10.6)

36 (13.7)

Ā 

ā€ƒā‰„ā€‰10

185 (88.9)

225 (85.6)

Ā 

PVTT

ā€ƒ1

30 (14.4)

40 (15.3)

0.716

ā€ƒ2

131 (63.0)

163 (62.0)

Ā 

ā€ƒ3

47 (22.1)

60 (22.8)

Ā 

Year of surgery

ā€ƒ2008

70 (33.7)

79 (30.0)

0.882

ā€ƒ2009

33 (15.9)

42 (16.0)

Ā 

ā€ƒ2010

31 (14.9)

46 (17.5)

Ā 

ā€ƒ2011

31 (14.9)

37 (14.1)

Ā 

ā€ƒ2012

43 (20.7)

59 (22.4)

Ā 
Ā 

Mean (SD)

Mean (SD)

Ā 

Age (yr)

48.0 (10.94)

49.0 (9.73)

0.078

Ā 

Median (IQR)

Median (IQR)

Ā 

WBC (109/L)

5.5 (4.2, 7.3)

5.4 (4.3, 7.1)

0.06

ALT (U/L)

47.8 (31.0, 66.0)

45.0 (29.1, 67.3)

0.903

AST (U/L)

49.0 (37.0, 69.0)

52.0 (35.0, 71.0)

0.820

  1. ASA American Society of Anesthesiologists, PVTT Portal vein tumor thrombus, INHA Volatile inhalational anesthesia, TIVA Total IV anesthesia, WBC White blood cells, NLR Neutrophilā€“lymphocytes ratio
  2. a Including 4 patients with HBsAgāˆ’ā€‰+ā€‰and anti-HCVā€‰āˆ’ā€‰+